|
1
|
Bade BC and Dela Cruz CS: Lung cancer
2020: Epidemiology, etiology, and prevention. Clin Chest Med.
41:1–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rossi A and Di Maio M: Platinum-based
chemotherapy in advanced non-small-cell lung cancer: Optimal number
of treatment cycles. Expert Rev Anticancer Ther. 16:653–660. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olaussen KA, Dunant A, Fouret P, Brambilla
E, André F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH,
et al: DNA repair by ERCC1 in non-small-cell lung cancer and
cisplatin-based adjuvant chemotherapy. N Engl J Med. 355:983–991.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitsudomi T, Morita S, Yatabe Y, Negoro S,
Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, et
al: Gefitinib versus cisplatin plus docetaxel in patients with
non-small-cell lung cancer harbouring mutations of the epidermal
growth factor receptor (WJTOG3405): An open label, randomised phase
3 trial. Lancet Oncol. 11:121–128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scagliotti GV, Parikh P, von Pawel J,
Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U,
Digumarti R, Zukin M, et al: Phase III study comparing cisplatin
plus gemcitabine with cisplatin plus pemetrexed in
chemotherapy-naive patients with advanced-stage non-small-cell lung
cancer. J Clin Oncol. 26:3543–3551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ben-Baruch A: Inflammation-associated
immune suppression in cancer: The roles played by cytokines,
chemokines and additional mediators. Semin Cancer Biol. 16:38–52.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luboshits G, Shina S, Kaplan O, Engelberg
S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben-Baruch
A: Elevated expression of the CC chemokine regulated on activation,
normal T cell expressed and secreted (RANTES) in advanced breast
carcinoma. Cancer Res. 59:4681–4687. 1999.PubMed/NCBI
|
|
10
|
Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki
Y and Abe A: Correlation of tissue and plasma RANTES levels with
disease course in patients with breast or cervical cancer. Clin
Cancer Res. 7:285–289. 2001.PubMed/NCBI
|
|
11
|
Yaal-Hahoshen N, Shina S, Leider-Trejo L,
Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I and
Ben-Baruch A: The chemokine CCL5 as a potential prognostic factor
predicting disease progression in stage II breast cancer patients.
Clin Cancer Res. 12:4474–4480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aldinucci D, Borghese C and Casagrande N:
The CCL5/CCR5 axis in cancer progression. Cancers (Basel).
12:17652020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aldinucci D and Casagrande N: Inhibition
of the CCL5/CCR5 axis against the progression of gastric cancer.
Int J Mol Sci. 19:14772018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou B, Sun C, Li N, han W, Lu H, Guo L,
Guo E, Xia M, Weng D, Meng L, et al: Cisplatin-induced CCL5
secretion from CAFs promotes cisplatin-resistance in ovarian cancer
via regulation of the STAT3 and PI3K/Akt signaling pathways. Int J
Oncol. 48:2087–2097. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang R, Wang S, Wang N, Zheng Y, Zhou J,
Yang B, Wang X, Zhang J, Guo L, Wang S, et al: CCL5 derived from
tumor-associated macrophages promotes prostate cancer stem cells
and metastasis via activating β-catenin/STAT3 signaling. Cell Death
Dis. 11:2342020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chuang JY, Yang WH, Chen HT, Huang CY, Tan
TW, Lin YT, Hsu CJ, Fong YC and Tang CH: CCL5/CCR5 axis promotes
the motility of human oral cancer cells. J Cell Physiol.
220:418–426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Velasco-Velázquez M, Jiao X, De La Fuente
M, Pestell TG, Ertel A, Lisanti MP and Pestell RG: CCR5 antagonist
blocks metastasis of basal breast cancer cells. Cancer Res.
72:3839–3850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koontongkaew S: The tumor microenvironment
contribution to development, growth, invasion and metastasis of
head and neck squamous cell carcinomas. J Cancer. 4:66–83. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Erdogan B and Webb DJ: Cancer-associated
fibroblasts modulate growth factor signaling and extracellular
matrix remodeling to regulate tumor metastasis. Biochem Soc Trans.
45:229–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ernst C and Morton CC: Identification and
function of long non-coding RNA. Front Cell Neurosci. 7:1682013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Loewer S, Cabili MN, Guttman M, Loh YH,
Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, et al:
Large intergenic non-coding RNA-RoR modulates reprogramming of
human induced pluripotent stem cells. Nat Genet. 42:1113–1117.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gregg C, Zhang J, Weissbourd B, Luo S,
Schroth GP, Haig D and Dulac C: High-resolution analysis of
parent-of-origin allelic expression in the mouse brain. Science.
329:643–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
LncRNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shao TR, Zheng ZN, Chen YC, Wu QQ, Huang
GZ, Li F, Zeng WS and Lv XZ: LncRNA AC007271.3 promotes cell
proliferation, invasion, migration and inhibits cell apoptosis of
OSCC via the Wnt/β-catenin signaling pathway. Life Sci.
239:1170872019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Zhang P, Wang L, Piao HL and Ma
L: Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
Acta Biochim Biophys Sin (Shanghai). 46:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wan Y and Chang HY: HOTAIR: Flight of
noncoding RNAs in cancer metastasis. Cell Cycle. 9:3391–3392. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao W, An Y, Liang Y and Xie XW: Role of
HOTAIR long noncoding RNA in metastatic progression of lung cancer.
Eur Rev Med Pharmacol Sci. 18:1930–1936. 2014.PubMed/NCBI
|
|
31
|
Nakagawa T, Endo H, Yokoyama M, Abe J,
Tamai K, Tanaka N, Sato I, Takahashi S, Kondo T and Satoh K: Large
noncoding RNA HOTAIR enhances aggressive biological behavior and is
associated with short disease-free survival in human non-small cell
lung cancer. Biochem Biophys Res Commun. 436:319–324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu MY, Li XQ, Gao TH, Cui Y, Ma N, Zhou Y
and Zhang GJ: Elevated HOTAIR expression associated with cisplatin
resistance in non-small cell lung cancer patients. J Thorac Dis.
8:3314–3322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo J, Dou D, Zhang T and Wang B: HOTAIR
promotes cisplatin resistance of osteosarcoma cells by regulating
cell proliferation, invasion, and apoptosis via miR-106a-5p/STAT3
axis. Cell Transplant. Aug 6–2020.(Epub ahead of print). doi:
10.1177/0963689720948447. View Article : Google Scholar
|
|
34
|
Zhang Y, Ai H, Fan X, Chen S, Wang Y and
Liu L: Knockdown of long non-coding RNA HOTAIR reverses cisplatin
resistance of ovarian cancer cells through inhibiting
miR-138-5p-regulated EZH2 and SIRT1. Biol Res. 53:182020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li J, Guan J, Long X, Wang Y and Xiang X:
mir-1-mediated paracrine effect of cancer-associated fibroblasts on
lung cancer cell proliferation and chemoresistance. Oncol Rep.
35:3523–3531. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Augsten M: Cancer-associated fibroblasts
as another polarized cell type of the tumor microenvironment. Front
Oncol. 4:622014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yi Y, Zeng S, Wang Z, Wu M, Ma Y, Ye X,
Zhang B and Liu H: Cancer-associated fibroblasts promote
epithelial-mesenchymal transition and EGFR-TKI resistance of
non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling. Biochim
Biophys Acta Mol Basis Dis. 1864:793–803. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhan Y, Abuduwaili K, Wang X, Shen Y,
Nuerlan S and Liu C: Knockdown of long non-coding RNA HOTAIR
suppresses cisplatin resistance, cell proliferation, migration and
invasion of DDP-resistant NSCLC Cells by targeting
miR-149-5p/doublecortin-like kinase 1 axis. Cancer Manag Res.
12:7725–7737. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang J, Ke P, Guo L, Wang W, Tan H, Liang
Y and Yao S: Lentivirus-mediated RNA interference targeting the
long noncoding RNA HOTAIR inhibits proliferation and invasion of
endometrial carcinoma cells in vitro and in vivo. Int J Gynecol
Cancer. 24:635–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pei CS, Wu HY, Fan FT, Wu Y, Shen CS and
Pan LQ: Influence of curcumin on HOTAIR-mediated migration of human
renal cell carcinoma cells. Asian Pac J Cancer Prev. 15:4239–4243.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qiu JJ, Wang Y, Ding JX, Jin HY, Yang G
and Hua KQ: The long non-coding RNA HOTAIR promotes the
proliferation of serous ovarian cancer cells through the regulation
of cell cycle arrest and apoptosis. Exp Cell Res. 333:238–248.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li D, Chai L, Yu X, Song Y, Zhu X, Fan S,
Jiang W, Qiao T, Tong J, Liu S, et al: The HOTAIRM1/miR-107/TDG
axis regulates papillary thyroid cancer cell proliferation and
invasion. Cell Death Dis. 11:2272020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J
and Liu M: Long intergenic noncoding RNA HOTAIR is overexpressed
and regulates PTEN methylation in laryngeal squamous cell
carcinoma. Am J Pathol. 182:64–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Galluzzi L, Vitale I, Michels J, Brenner
C, Szabadkai G, Harel-Bellan A, Castedo M and Kroemer G: Systems
biology of cisplatin resistance: Past, present and future. Cell
Death Dis. 5:e12572014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA,
Ling TY, Yu SL, Yuan SS, Chen YJ, Lin CY, et al: Cancer-associated
fibroblasts regulate the plasticity of lung cancer stemness via
paracrine signalling. Nat Commun. 5:34722014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wintzell M, Hjerpe E, Åvall Lundqvist E
and Shoshan M: Protein markers of cancer-associated fibroblasts and
tumor-initiating cells reveal subpopulations in freshly isolated
ovarian cancer ascites. BMC Cancer. 12:3592012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tao L, Huang G, Wang R, Pan Y, He Z, Chu
X, Song H and Chen L: Cancer-associated fibroblasts treated with
cisplatin facilitates chemoresistance of lung adenocarcinoma
through IL-11/IL-11R/STAT3 signaling pathway. Sci Rep. 6:384082016.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shintani Y, Fujiwara A, Kimura T, Kawamura
T, Funaki S, Minami M and Okumura M: IL-6 secreted from
cancer-associated fibroblasts mediates chemoresistance in NSCLC by
increasing epithelial-mesenchymal transition signaling. J Thorac
Oncol. 11:1482–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lapteva N, Aldrich M, Weksberg D, Rollins
L, Goltsova T, Chen SY and Huang XF: Targeting the intratumoral
dendritic cells by the oncolytic adenoviral vaccine expressing
RANTES elicits potent antitumor immunity. J Immunother. 32:145–156.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Taub DD, Sayers TJ, Carter CR and Ortaldo
JR: Alpha and beta chemokines induce NK cell migration and enhance
NK-mediated cytolysis. J Immunol. 155:3877–3888. 1995.PubMed/NCBI
|
|
54
|
Böttcher JP, Bonavita E, Chakravarty P,
Blees H, Cabeza-Cabrerizo M, Sammicheli S, Rogers NC, Sahai E,
Zelenay S and Reis e Sousa C: NK cells stimulate recruitment of
cDC1 into the tumor microenvironment promoting cancer immune
control. Cell. 172:1022–1037.e14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Simon PS, Bardhan K, Chen MR, Paschall AV,
Lu C, Bollag RJ, Kong FC, Jin J, Kong FM, Waller JL, et al: NF-κB
functions as a molecular link between tumor cells and Th1/Tc1 T
cells in the tumor microenvironment to exert radiation-mediated
tumor suppression. Oncotarget. 7:23395–23415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Araujo JM, Gomez AC, Aguilar A, Salgado R,
Balko JM, Bravo L, Doimi F, Bretel D, Morante Z, Flores C, et al:
Effect of CCL5 expression in the recruitment of immune cells in
triple negative breast cancer. Sci Rep. 8:48992018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li W, Zhang X, Wang J, Li M, Cao C, Tan J,
Ma D and Gao Q: TGFβ1 in fibroblasts-derived exosomes promotes
epithelial-mesenchymal transition of ovarian cancer cells.
Oncotarget. 8:96035–96047. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim
SW and Kim YT: Long non-coding RNA HOTAIR is associated with human
cervical cancer progression. Int J Oncol. 46:521–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Oh EJ, Kim SH, Yang WI, Ko YH and Yoon SO:
Long non-coding RNA HOTAIR expression in diffuse large B-cell
lymphoma: In relation to polycomb repressive complex pathway
proteins and H3K27 trimethylation. J Pathol Transl Med. 50:369–376.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yang X, Luo E, Liu X, Han B, Yu X and Peng
X: Delphinidin-3-glucoside suppresses breast carcinogenesis by
inactivating the Akt/HOTAIR signaling pathway. BMC Cancer.
16:4232016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ni W, Yao S, Zhou Y, Liu Y, Huang P, Zhou
A, Liu J, Che L and Li J: Long noncoding RNA GAS5 inhibits
progression of colorectal cancer by interacting with and triggering
YAP phosphorylation and degradation and is negatively regulated by
the m6A reader YTHDF3. Mol Cancer. 18:1432019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu J, Tian W, Zhang W, Jia Y, Yang X,
Wang Y and Zhang J: MicroRNA-142-3p/MALAT1 inhibits lung cancer
progression through repressing β-catenin expression. Biomed
Pharmacother. 114:1088472019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lan T, Li H, Zhang D, Xu L, Liu H, Hao X,
Yan X, Liao H, Chen X, Xie K, et al: KIAA1429 contributes to liver
cancer progression through N6-methyladenosine-dependent
post-transcriptional modification of GATA3. Mol Cancer. 18:1862019.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yao Y, Li J and Wang L: Large intervening
non-coding RNA HOTAIR is an indicator of poor prognosis and a
therapeutic target in human cancers. Int J Mol Sci. 15:18985–18999.
2014. View Article : Google Scholar : PubMed/NCBI
|
